Clinical characteristics of 18 E/R-positive relapse cases that were analyzed with SNP arrays
Patient ID . | Sex . | Age, y . | Remission, mo . | Relapse site . | MRD . | Outcome, mo . | Source . |
---|---|---|---|---|---|---|---|
1 | Male | 3.7 | 46 | BM | NA | SCT, relapse,* | Germany |
2 | Male | 4.2 | 51 | BM | NA | SCT, remission 96 | Germany |
3 | Male | 2.3 | 19 | BM | NA | SCT, relapse* | Austria |
4 | Male | 3.7 | 78 | BM | IR | SCT* | Austria |
5 | Male | 4.3 | 50 | BM | LR | Remission 126 | Austria |
6 | Male | 3.4 | 16 | BM | IR | SCT, remission 86 | Austria |
7 | Male | 2.1 | 43 | BM | NA | SCT, remission 78 | Austria |
8 | Male | 4.7 | 40 | BM | NA | Remission 21 | Austria |
9 | Female | 3.6 | 32 | BM | IR | SCT, remission 23 | Austria |
10 | Male | 9.3 | 29 | BM | IR | SCT, relapse, remission 26 | Austria |
11 | Male | 3.3 | 79 | Testis | IR | SCT, remission 69 | Austria |
12 | Male | NA | NA | BM | NA | NA | St Jude #48 |
13 | Female | NA | NA | BM | NA | NA | St Jude #49 |
14 | Male | 3.2 | 68 | BM | LR | Remission 14 | Germany |
15 | Male | 4.5 | 27 | BM | IR | Remission 35 | Germany |
16 | Male | NA | NA | BM | NA | NA | St Jude #10 |
17 | Male | NA | NA | BM | NA | NA | St Jude #44 |
18 | Female | NA | NA | BM | NA | NA | St Jude #50 |
Patient ID . | Sex . | Age, y . | Remission, mo . | Relapse site . | MRD . | Outcome, mo . | Source . |
---|---|---|---|---|---|---|---|
1 | Male | 3.7 | 46 | BM | NA | SCT, relapse,* | Germany |
2 | Male | 4.2 | 51 | BM | NA | SCT, remission 96 | Germany |
3 | Male | 2.3 | 19 | BM | NA | SCT, relapse* | Austria |
4 | Male | 3.7 | 78 | BM | IR | SCT* | Austria |
5 | Male | 4.3 | 50 | BM | LR | Remission 126 | Austria |
6 | Male | 3.4 | 16 | BM | IR | SCT, remission 86 | Austria |
7 | Male | 2.1 | 43 | BM | NA | SCT, remission 78 | Austria |
8 | Male | 4.7 | 40 | BM | NA | Remission 21 | Austria |
9 | Female | 3.6 | 32 | BM | IR | SCT, remission 23 | Austria |
10 | Male | 9.3 | 29 | BM | IR | SCT, relapse, remission 26 | Austria |
11 | Male | 3.3 | 79 | Testis | IR | SCT, remission 69 | Austria |
12 | Male | NA | NA | BM | NA | NA | St Jude #48 |
13 | Female | NA | NA | BM | NA | NA | St Jude #49 |
14 | Male | 3.2 | 68 | BM | LR | Remission 14 | Germany |
15 | Male | 4.5 | 27 | BM | IR | Remission 35 | Germany |
16 | Male | NA | NA | BM | NA | NA | St Jude #10 |
17 | Male | NA | NA | BM | NA | NA | St Jude #44 |
18 | Female | NA | NA | BM | NA | NA | St Jude #50 |
MRD indicates minimal residual disease; NA, not available; SCT, hematopoietic stem cell transplantation; IR, intermediate risk; and LR, low risk.
Death.